Cyclacel Pharmaceuticals ... (CYCC)
undefined
undefined%
At close: undefined
0.43
-2.25%
Pre-market Jan 07, 2025, 04:30 AM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00
Cash & Equivalents 3.38M 18.34M 36.56M 33.41M 11.88M 17.50M 23.91M 16.52M 20.44M 24.19M 31.15M 16.41M 24.45M 29.50M 11.49M 24.22M 30.99M 44.24M 13.60M 13.90M 2.24M n/a n/a n/a
Short-Term Investments n/a n/a n/a n/a n/a n/a 132.00K 132.00K 132.00K 132.00K 132.00K 153.00K n/a n/a n/a 1.50M 27.77M 9.76M 6.93M 33.42M 11.30M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 1.26M 2.92M 1.55M -1.33M -1.29M n/a n/a n/a n/a n/a 72.00K 353.00K n/a n/a 196.00K 195.00K 196.00K 241.00K 347.00K 1.06M 1.67M n/a n/a n/a
Receivables 2.93M n/a n/a 1.31M 1.33M n/a n/a 2.06M 3.03M 3.46M 2.31M n/a n/a n/a n/a n/a 2.47M 2.48M n/a n/a n/a n/a n/a n/a
Inventory n/a -5.64M 577.00K 684.00K 703.00K 609.00K 495.00K 999.00K 968.00K 1.07M 3.03M n/a 182.00K 174.00K 145.00K 508.00K 213.00K 1.37M n/a n/a n/a n/a n/a n/a
Other Current Assets 1.13M 7.04M 4.38M 750.00K 806.00K 2.28M 1.93M 1.04M 1.10M 1.35M 1.72M 2.46M 1.20M 1.38M 1.73M 2.78M 2.34M 4.06M 3.22M 1.02M 519.00K n/a n/a n/a
Total Current Assets 7.44M 24.41M 40.94M 35.47M 14.02M 19.79M 25.97M 19.62M 24.57M 29.00M 35.17M 18.87M 25.83M 31.05M 13.37M 29.01M 63.78M 58.16M 20.92M 48.34M 14.06M n/a n/a n/a
Property-Plant & Equipment 102.00K 174.00K 94.00K 1.33M 1.29M 36.00K 29.00K 45.00K 198.00K 387.00K 275.00K 129.00K 167.00K 408.00K 901.00K 1.75M 3.02M 2.12M 176.00K 6.21M 2.77M n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.92M 2.75M n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 1.36M 3.09M 1.65M 1.33M 1.29M 36.00K 29.00K 45.00K 198.00K 387.00K 347.00K 482.00K 167.00K 408.00K 1.10M 1.94M 12.13M 5.11M 523.00K 7.26M 4.44M n/a n/a n/a
Total Assets 8.80M 27.50M 42.59M 36.80M 15.31M 19.82M 26.00M 19.66M 24.76M 29.39M 35.52M 19.35M 26.00M 31.46M 14.47M 30.96M 75.91M 63.28M 21.45M 55.60M 18.50M 21.54M 24.73M 28.48M
Account Payables 3.54M 2.56M 2.12M 514.00K 890.00K 2.72M 1.56M 2.50M 1.94M 2.79M 2.54M 2.26M 1.72M 1.72M 1.71M 754.00K 4.96M 2.17M 2.16M 1.71M 954.00K n/a n/a n/a
Deferred Revenue n/a n/a n/a n/a n/a 150.00K 150.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.23M n/a 47.00K 1.26M n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 89.00K 251.00K 1.56M 12.50M n/a n/a n/a
Other Current Liabilities 4.62M 4.95M 3.18M 1.97M 1.53M 1.73M 2.56M 2.76M 3.81M 4.70M 4.95M 7.08M 4.78M 4.81M 8.11M 7.87M 9.75M 5.66M 2.81M 4.10M 1.26M n/a n/a n/a
Total Current Liabilities 8.16M 7.39M 5.29M 2.49M 2.42M 4.45M 4.11M 5.26M 5.75M 7.49M 7.50M 9.34M 6.50M 6.54M 9.82M 8.63M 14.71M 7.92M 5.22M 7.41M 14.71M n/a n/a n/a
Long-Term Debt 37.00K 106.00K 30.00K 1.06M 1.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 626.00K n/a n/a 78.00K 2.68M n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a 100.00K 124.00K 130.00K 176.00K 206.00K n/a n/a n/a n/a n/a 1.06M 3.23M 1.44M 1.54M 631.00K 68.63M n/a n/a n/a
Total Long-Term Liabilities 37.00K 4.60M 30.00K 1.06M 1.19M 100.00K 124.00K 130.00K 176.00K 206.00K n/a n/a n/a n/a n/a 1.69M 3.23M 1.44M 1.62M 4.07M 68.63M n/a n/a n/a
Total Liabilities 8.20M 11.99M 5.32M 3.54M 3.61M 4.55M 4.24M 5.39M 5.93M 7.70M 7.50M 9.34M 6.50M 6.54M 9.82M 10.31M 17.94M 9.36M 6.84M 11.48M 83.34M 69.66M 60.99M 53.86M
Total Debt 37.00K 106.00K 30.00K 1.06M 1.19M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 626.00K 10.00K 89.00K 2.07M 4.23M 11.65M n/a n/a n/a
Common Stock 1K 4.50M 10.00K 6.00K 17.00K 12.00K 12.00K 4.00K 35.00K 23.00K 19.00K 9.00K 54.00K 47.00K 26.00K 20.00K 20.00K 16.00K 19.00K 19.00K 2.00K n/a n/a n/a
Retained Earnings -428.28M -406.16M -384.96M -366.07M -357.63M -349.80M -342.51M -335.04M -323.16M -308.82M -289.43M -270.25M -257.06M -241.82M -222.28M -202.72M -162.33M -138.28M -155.60M -126.18M -86.59M -68.14M -48.69M -29.17M
Comprehensive Income -908.00K -1.32M -748.00K -746.00K -819.00K -760.00K -794.00K -743.00K -596.00K -480.00K -109.00K 48.00K 57.00K 31.00K 20.00K -42.00K -2.63M -2.54M -193.00K -1.43M -2.78M n/a n/a n/a
Shareholders Equity 607.00K 15.51M 37.26M 33.26M 11.70M 15.27M 21.77M 14.27M 18.84M 21.69M 28.02M 10.02M 19.50M 24.92M 4.64M 20.64M 57.97M 53.92M 14.60M 44.12M -64.84M -48.13M -36.26M -25.38M
Total Investments n/a n/a n/a n/a n/a n/a 132.00K 132.00K 132.00K 132.00K 132.00K 153.00K n/a n/a n/a 1.50M 27.77M 9.76M 6.93M 33.42M 11.30M n/a n/a n/a